Search - tctmd.com

Displaying 241 - 260 of 488

Sort: Relevancy | Date

News Daily News

2 Estudios Avalan el Uso de Dispositivos liberadores de Paclitaxel en el Tratamiento de la Enfermedad Femoropoplítea

Caitlin E. Cox

April 05, 2013

Presentation

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Presenter: Antonio Micari

April 03, 2013

Presentation

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Presenter: T. Zeller

April 03, 2013

News Daily News

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

March 25, 2013

News Daily News

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

March 25, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Conference News ACC 2013

Pair of Studies Show Positive Stent Results at ACC

Yael L. Maxwell

March 08, 2013

News Daily News

BBC ONE: Simple, Complex Bifurcation Stenting Both Improve QoL

L.A. McKeown

February 24, 2013

News Daily News

BBC ONE: La Impantación Simple y Compleja de Stents Bifurcados Mejora la Calidad de Vida

L.A. McKeown

February 24, 2013

Presentation

Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis After DES Implantation

Presenter: Robert A. Byrne

February 07, 2013

News Daily News

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

Caitlin E. Cox

February 07, 2013

Presentation TCT 2013

Paclitaxel Balloon Delivery Results In Homogeneous In-Stent Neointimal Distribution and Reduction of Stent Edge Stenosis Progression in the Peripheral Swine Model

Presenter: Maxwell Afari, Armando Tellez, Seung-Jin Oh, Piotr Buszman, Yanping Cheng, Jong Shiuan Yeh, Gerard Conditt, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Vascular Injury Influences Drug Transfer and Vessel Healing Following Paclitaxel Coated Balloon Delivery in the Peripheral Arteries of Swine

Presenter: Maxwell Afari, Taylor Palmieri, Armando Tellez, Piotr Buszman, Krzysztof Milewski, Yanping Cheng, Seung-Jin Oh, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Presenter: Aris Moschovitis, Giulio Stefanini, Michael Magro, Lorenz R?ber, Bindu Kalesan, Masanori Taniwaki, Joost Daemen, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Presentation TCT 2013

PAclitaxel-eluting Balloon In Primary Percutaneous Coronary Intervention In Amsterdam (PAPPA): Sustained Safety And Efficacy At 12 Months Follow-up.

Presenter: Nicola Vos, Maurits Dirksen, Ferdinand Van Nooijen, Ton Slagboom, Giovanni Amoroso, Ferdinand Kiemeneij, Mark Patterson, Jean-Paul Herrman, Ren? Van der Schaaf

January 31, 2013

Presentation TCT 2013

Paclitaxel Drug Eluting Balloon Versus Standard Angioplasty To Reduce Restenosis In Diabetic Patients With In Stent Restenosis Of The Superficial Femoral And Proximal Popliteal...

Presenter: Francesco Liistro, Paolo Angioli, Guido Bellandi, Leonardo Bolognese, Kenneth Ducci, Italo Porto, Filippo Turini, Giorgio Ventoruzzo

January 31, 2013

Presentation TCT 2013

Neointimal Tissue Characteristics Based on Optical Coherence Tomography Analysis Following Paclitaxel Coated Balloon Treatment in a Porcine Iliofemoral Vascular Territory

Presenter: Maxwell Afari, Seung-Jin Oh, Piotr Buszman, Armando Tellez, Athanasios Peppas, William Rate, Jong Shiuan Yeh, Greg Kaluza, Juan Granada

January 31, 2013

Presentation TCT 2013

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

Presenter: Maxwell Afari, Armando Tellez, Seung-Jin Oh, Krzysztof Milewski, Piotr Buszman, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Impact of Baseline Peri-Stent Plaque Volume on Positive Vessel Remodeling after Implantation of Paclitaxel Eluting Stents: A Pooled Volumetric Intravascular Ultrasound Analysis

Presenter: Kenji Sakamoto, Katsuhisa Waseda, Hideki Kitahara, Ryotaro Yamada, Ching-Chang Huang, Paul Yock, Peter Fitzgerald, Yasuhiro Honda

January 31, 2013

Presentation TCT 2013

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Presenter: Sachin Goel, Wael El-Mallah, Mobolaji Ige, Supriya Gupta, E Murat Tuzcu, Stephen Ellis, Samir Kapadia

January 31, 2013

Advertisement

2 Estudios Avalan el Uso de Dispositivos liberadores de Paclitaxel en el Tratamiento de la Enfermedad Femoropoplítea

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

BIOSOLVE-1 Confirma la Mejora en los Stents Bioabsorbibles liberadores de Paclitaxel

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

Pair of Studies Show Positive Stent Results at ACC

BBC ONE: Simple, Complex Bifurcation Stenting Both Improve QoL

BBC ONE: La Impantación Simple y Compleja de Stents Bifurcados Mejora la Calidad de Vida

Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis After DES Implantation

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

Paclitaxel Balloon Delivery Results In Homogeneous In-Stent Neointimal Distribution and Reduction of Stent Edge Stenosis Progression in the Peripheral Swine Model

Vascular Injury Influences Drug Transfer and Vessel Healing Following Paclitaxel Coated Balloon Delivery in the Peripheral Arteries of Swine

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

PAclitaxel-eluting Balloon In Primary Percutaneous Coronary Intervention In Amsterdam (PAPPA): Sustained Safety And Efficacy At 12 Months Follow-up.

Paclitaxel Drug Eluting Balloon Versus Standard Angioplasty To Reduce Restenosis In Diabetic Patients With In Stent Restenosis Of The Superficial Femoral And Proximal Popliteal...

Neointimal Tissue Characteristics Based on Optical Coherence Tomography Analysis Following Paclitaxel Coated Balloon Treatment in a Porcine Iliofemoral Vascular Territory

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

Impact of Baseline Peri-Stent Plaque Volume on Positive Vessel Remodeling after Implantation of Paclitaxel Eluting Stents: A Pooled Volumetric Intravascular Ultrasound Analysis

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content